SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-068833
Filing Date
2021-12-09
Accepted
2021-12-09 17:18:18
Documents
2
Period of Report
2021-12-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2689
2 POA DOCUMENT poa.txt EX-24 3665
  Complete submission text file 0001209191-21-068833.txt   8021
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Issuer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KALEIDO BIOSCIENCES, INC. 65 HAYDEN AVE. LEXINGTON MA 02421
Business Address
Knobil Katharine (Reporting) CIK: 0001768011 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37939 | Film No.: 211482815